Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 USD | -9.73% | +0.99% | -26.09% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 82.33 | 56.6 | 59.67 | 44.9 | - | - |
Enterprise Value (EV) 1 | 82.33 | 56.6 | 59.67 | 44.9 | 44.9 | 44.9 |
P/E ratio | - | - | - | -1.44 x | -1.56 x | -1.43 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | -5.96 x | - | - | -1.5 x | -1.45 x | -1.34 x |
FCF Yield | -16.8% | - | - | -66.6% | -69% | -74.4% |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 18,755 | 24,502 | 43,241 | 44,020 | - | - |
Reference price 2 | 4.390 | 2.310 | 1.380 | 1.020 | 1.020 | 1.020 |
Announcement Date | 3/17/22 | 3/30/23 | 3/14/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | - | -14.65 | -28.52 | -30.34 | -33.37 | -40.06 | -50.77 |
Operating Margin | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | - | - | - | -37 | -44.64 | -54.28 |
Net income 1 | -8.557 | - | - | - | -37 | -44.64 | -54.28 |
Net margin | - | - | - | - | - | - | - |
EPS 2 | -3.020 | - | - | - | -0.7100 | -0.6533 | -0.7133 |
Free Cash Flow 1 | - | -13.82 | - | - | -29.9 | -31 | -33.4 |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 3/31/21 | 3/17/22 | 3/30/23 | 3/14/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -5.849 | -6.145 | -7.179 | -7.399 | -7.798 | -7.525 | -7.715 | -7.169 | -7.928 | -8.562 | -8.012 | -8.181 | -8.512 | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | - | - | - | - | - | - | - | - | -8.562 | -8.953 | -9.486 | -9.976 | - | - |
Net income 1 | - | - | - | - | - | - | - | - | - | -8.562 | -8.953 | -9.486 | -9.976 | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | - | - | - | - | - | - | - | - | - | -0.2000 | -0.1850 | -0.1850 | -0.1550 | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/17/22 | 5/12/22 | 8/12/22 | 11/10/22 | 3/30/23 | 5/12/23 | 8/10/23 | 11/9/23 | 3/14/24 | 5/9/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | -13.8 | - | - | -29.9 | -31 | -33.4 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share 2 | - | - | - | - | -0.9200 | -0.7200 | -0.5700 |
Capex 1 | - | - | - | - | 0.16 | 0.33 | 0.4 |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 3/31/21 | 3/17/22 | 3/30/23 | 3/14/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.09% | 49.74M | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- INAB Stock
- Financials IN8bio, Inc.